Stock Groups

Hologic Earnings, Revenue Beat in Q4 -Breaking

by Mike Robinson

[ad_1]

© Reuters. The Revenue Beats in Quarter Four for Hologic

On Monday, Hologic (NASDAQ) reported that the fourth quarter beat analyst forecasts. The company also posted a record revenue.

Hologic posted earnings per share (EPS) of $1.61 for revenue $1.32B. Investing.com polled analysts and predicted EPS at $0.9987 for revenue $1.04B.

Hologic shares have fallen 0% over the past year. They are still 14.60% below the 52-week high of $85.00, set on February 16, 2016. They are under-performing the S&P 500 which is up 22.83% from the start of the year.

After-hours trading for Hologic shares increased by 3.32% following the release.

This month, Hologic is following other important earnings in the Healthcare sector

Hologic’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific’s third quarter earnings per share (EPS) was $5.76 on $9.33B in revenue, beating expectations. That compares with the $4.68 forecast on $8.38B revenue.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]